Prognostic value of subclassification of T2 tumours in patients with gastric cancer

British Journal of Surgery

Volumn 96, Issue 4, 2009, Pages 398-404

  Nitti, D ^a   Marchet, A ^a   Mocellin, S ^a   Rossi, G M ^a   Ambrosi, A ^b   Mencarelli, R ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c ROVIGO GENERAL HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMACH TUMOR; CLASSIFICATION; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 63049132507     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6487     Document Type: Article

References (23)

1. Siewert JR,B̈ ottcher K, Stein HJ, Roder J. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461.
2. Bozzetti F, Bonfanti G, Morabito T, Bufalino R, Menotti V, Andreola S et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 1986; 162: 229-234.
3. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-315.
4. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005; 241: 27-39.
5. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981; 11: 127-139.
6. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma (2nd English edn). Gastric Cancer 1998; 1: 10-24.
7. Sobin LH, Wittekind CH (eds). International Union Against Cancer (UICC). TNM Classification of Malignant Tumors (5th edn). JohnWiley & Sons: New York, 1997.
8. Sarela AI, Turnbull AD, Coit DG, Klimstra D, Brennan MF, Karpeh MS et al. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann Surg Oncol 2003; 10: 783-791.
9. Park do J, Kong SH, Lee HJ, KimWH, Yang HK, Lee KU et al. Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status. Surgery 2007; 141: 757-763.
10. Komatsu S, Ichikawa D, Kurioka H, Kan K, Shioaki Y, Ueshima Y et al. Prognostic and clinical evaluation of patients with T2 gastric cancer. Hepatogastroenterology 2005; 52: 965-968.
11. Fotia G, Marrelli D, De Stefano A, Pinto E, Roviello F. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer. Eur J Surg Oncol 2004; 30: 930-934.
12. Maehara Y, Anai H, Moriguchi S, Watanabe A, Tsujitani S, Sugimachi K. Gastric carcinoma invading muscularis propria and macroscopic appearance. Eur J Surg Oncol 1992; 18: 131-134.
13. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007; 245: 543-552.
14. Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 2008; 34: 159-165.
15. Compton CC, Sobin LH. Protocol for the examination of specimens removed from patients with gastric carcinoma: a basis for checklists. Members of the Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens From Patients With Gastric Cancer. Arch Pathol Lab Med 1998; 122: 9-14.
16. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG et al. AJCC Cancer Staging Manual (6th edn). Springer-Verlag: New York, 2002.
17. Abe S, Yoshimura H, Nagoaka S, Monden N, Kinugasa S, Nagasue N et al. Long-term results of operation for carcinoma of the stomach in T1/T2 stages: critical evaluation of the concept of early carcinoma of the stomach. J Am Coll Surg 1995; 181: 389-396.
18. Isozachi H, Fujii K, Nomura E, Mabuchi H, Nishiguchi K, Hara H et al. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma). Hepatogastroenterology 1999; 46: 2669-2672.
19. Therneau TM, Grambsch PM, Flemming TR. Martingale-based residuals for survival models. Biometrika 1990; 77: 147-160.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
21. Hampel R, Ronchetti EM, Rousseew PJ, AtahelWA. Robust Statistic: The Approach Based on Influence Functions. Wiley: New York, 1986.
22. Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187-220.
23. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003; 10: 1077-1085.